Instadose Pharma (Instadose Pharma) Additional Paid-In Capital : $23.40 Mil(As of Feb. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Instadose Pharma Additional Paid-In Capital?

Instadose Pharma's quarterly additional paid-in capital increased from Aug. 2021 ($0.10 Mil) to Nov. 2021 ($0.41 Mil) and increased from Nov. 2021 ($0.41 Mil) to Feb. 2022 ($23.40 Mil).

Instadose Pharma's annual additional paid-in capital increased from Nov. 2019 ($-0.05 Mil) to Nov. 2020 ($0.02 Mil) and increased from Nov. 2020 ($0.02 Mil) to Nov. 2021 ($0.41 Mil).

Instadose Pharma Additional Paid-In Capital Historical Data

The historical data trend for Instadose Pharma's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instadose Pharma Additional Paid-In Capital Chart

Instadose Pharma Annual Data

Trend

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Additional Paid-In Capital

Get a 7-Day Free Trial

-0.05

0.02

0.41

Instadose Pharma Quarterly Data
	May17	Aug17	Nov17	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22
Additional Paid-In Capital	Get a 7-Day Free Trial															0.03	0.10	0.10	0.41	23.40

Instadose Pharma Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Instadose Pharma Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Instadose Pharma's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Instadose Pharma (Instadose Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Instadose Pharma Corp (OTCPK:INSD) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

5500 North Service Road, Suite 301, Burlington, ON, CAN, L7L 6W6

Website

https://www.instadosepharma.com

Instadose Pharma Corp, formerly Mikrocoze Inc is seeking to create a global distribution platform for medicinal cannabis and cannabinoid oil. The company endeavors to utilize the Global Distribution Platform to open the commercial gateway to a new wholesale marketplace along with providing pharmaceutical industry companies with large, sustainable, consistent, diverse, and low?cost supplies of high?quality medicinal cannabis and cannabinoid oil for use in bulk as an active pharmaceutical ingredient.